NI
ALBO

Numeric Investors’s Albireo Pharma Inc ALBO Stock Holding History

Numeric Investors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,161
Closed -$914K – 937
2014
Q1 		$914K Buy
11,161
+150
+1% +$13.7K 0.02% 462
2013
Q4 		$753K Sell
11,011
-10,371
-49% -$760K 0.01% 512
2013
Q3 		$2.02M Buy
+21,382
New +$2.78M 0.04% 338

Other funds holding ALBO

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Numeric Investors's ALBO Position: Q2 2014 in Review

Numeric Investors sold out of Albireo Pharma Inc (ALBO) in Q2 2014, closing a stake of 11,161 shares — an estimated $914K sold.

Numeric Investors first reported a position in ALBO in Q3 2013 and held it in 3 quarters. The position peaked at $2.02M in Q3 2013. 37 funds tracked by Wall St. Rank hold ALBO as of Q2 2014.

  • Numeric Investors reported no remaining Albireo Pharma Inc position as of Q2 2014 after selling out during the quarter.
  • Numeric Investors sold 11,161 Albireo Pharma Inc shares in Q2 2014, an estimated $914K.
  • Numeric Investors first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 3 quarters.
  • Numeric Investors's Albireo Pharma Inc position peaked at $2.02M in Q3 2013.
  • 37 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2014.

Based on Numeric Investors's 13F filing for Q2 2014, filed 11 Aug 2014.